These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29469014)
1. Effect of mineral status and glucocorticoid use on bone mineral density in patients with Crohn's disease. Pierote NR; Braz AF; Barros SL; Moita Neto JM; Parente JML; Silva MDCM; Beserra MS; Soares NRM; Marreiro DN; do Noscimento Nogueira N Nutrition; 2018 Apr; 48():13-17. PubMed ID: 29469014 [TBL] [Abstract][Full Text] [Related]
2. A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial. Klaus J; Haenle MM; Schröter C; Adler G; von Boyen G; Reinshagen M; von Tirpitz C Am J Gastroenterol; 2011 Apr; 106(4):786-93. PubMed ID: 21386830 [TBL] [Abstract][Full Text] [Related]
3. Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease. Tsujikawa T; Andoh A; Inatomi O; Bamba S; Nakahara T; Sasaki M; Saito H; Fujiyama Y Intern Med; 2009; 48(12):933-7. PubMed ID: 19525577 [TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in Iranian patients with inflammatory bowel disease. Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035 [TBL] [Abstract][Full Text] [Related]
5. Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease. van Hogezand RA; Bänffer D; Zwinderman AH; McCloskey EV; Griffioen G; Hamdy NA Osteoporos Int; 2006; 17(4):535-42. PubMed ID: 16392028 [TBL] [Abstract][Full Text] [Related]
6. Skeletal morbidity in inflammatory bowel disease. van Hogezand RA; Hamdy NA Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623 [TBL] [Abstract][Full Text] [Related]
7. Osteoporosis and determinants of bone density in patients with Crohn's disease. Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking. Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399 [TBL] [Abstract][Full Text] [Related]
10. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525 [TBL] [Abstract][Full Text] [Related]
11. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088 [TBL] [Abstract][Full Text] [Related]
12. Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control study. Krajcovicova A; Kuzma M; Hlavaty T; Hans D; Koller T; Jackuliak P; Leskova Z; Sturdik I; Killinger Z; Payer J Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):101-106. PubMed ID: 29064848 [TBL] [Abstract][Full Text] [Related]
13. Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids. Kotaniemi A; Savolainen A; Kautiainen H; Kröger H Pediatrics; 1993 Jun; 91(6):1127-30. PubMed ID: 8502514 [TBL] [Abstract][Full Text] [Related]
14. Bone density and bone metabolism in patients with inflammatory bowel disease. Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766 [TBL] [Abstract][Full Text] [Related]
15. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy. Loddenkemper K; Bohl N; Perka C; Burmester GR; Buttgereit F Rheumatol Int; 2006 Feb; 26(4):331-6. PubMed ID: 15887044 [TBL] [Abstract][Full Text] [Related]
16. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Boot AM; Bouquet J; Krenning EP; de Muinck Keizer-Schrama SM Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for the comorbidity of osteoporosis/osteopenia and kidney stones: a cross-sectional study. Zhu Z; Liu M; Zhang Y; Wu J; Gao M; Lei T; Huang F; Chen H; Wu M Arch Osteoporos; 2023 Oct; 18(1):128. PubMed ID: 37857823 [TBL] [Abstract][Full Text] [Related]
19. Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. von Tirpitz C; Epp S; Klaus J; Mason R; Hawa G; Brinskelle-Schmal N; Hofbauer LC; Adler G; Kratzer W; Reinshagen M Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1165-70. PubMed ID: 14560148 [TBL] [Abstract][Full Text] [Related]
20. Quantitative ultrasound of the proximal phalanges and dual-energy X-ray absorptiometry in Crohn's disease patients with osteopenia. von Tirpitz C; Klaus J; Steinkamp M; Mason R; Kratzer W; Adler G; Rieber A; Reinshagen M J Gastroenterol; 2003; 38(3):238-43. PubMed ID: 12673446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]